Chinese city targets pharma firms in graft crackdown

SHANGHAI, May 27 (Reuters) - China's eastern city of Hangzhou is cracking down on graft in the healthcare sector, according to an internal memo from the local government, putting more pressure on global drugmakers operating in the country.